LISA REED: Open Payments
NPI 1952510588 · BAY CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,225 in 126 payments from 18 companies in 2025. Trend: 2023 $2,319 · 2024 $3,005 · 2025 $2,225
Food & beverage: $2,225
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $454 |
| ABBVIE INC. | 32 | $403 |
| GENZYME CORPORATION | 10 | $227 |
| UCB, Inc. | 9 | $220 |
| Novartis Pharmaceuticals Corporation | 23 | $220 |
| Amgen Inc. | 6 | $113 |
| Lilly USA, LLC | 5 | $93 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $91 |
| Regeneron Healthcare Solutions, Inc. | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
Products named: TREMFYA, DUPIXENT, RINVOQ, Bimzelx, COSENTYX, SKYRIZI, OTEZLA, ILUMYA.
Industry payments across MI — which companies pay providers there.
